Overactive Bladder

Health-related quality of life and economic impact of urinary incontinence due to detrusor overactivity associated with a neurologic condition: A systematic review - Abstract

Published on Tuesday, 09 April 2013 16:45

BACKGROUND: Patients with neurologic diseases often have neurogenic detrusor overactivity (NDO), which can result in a loss of voluntary bladder control and uncontrollable urinary incontinence (UI).

Urinary neurotrophic factors in healthy individuals and patients with overactive bladder, "Beyond the Abstract," by Tiago Antunes-Lopes, MD

Published on Tuesday, 09 April 2013 13:06

BERKELEY, CA (UroToday.com) - Neurotrophins are expressed in the urothelium and these trophic factors, which are essential for the differentiation, survival, and maintenance of sensory neurons, have been considered key factors in the pathophysiology of overactive bladder (OAB).

Solifenacin succinate versus percutaneous tibial nerve stimulation in women with overactive bladder syndrome: Results of a randomized controlled crossover study - Abstract

Published on Friday, 05 April 2013 15:06

Aims: This study compared the effectiveness of solifenacin succinate (SS) versus percutaneous tibial nerve stimulation (PTNS) in women with overactive bladder syndrome (OABS).

Neurology and the bladder: How to assess and manage neurogenic bladder dysfunction. With particular references to neural control of micturition - Abstract

Published on Friday, 05 April 2013 12:08

Bladder dysfunctions are one of the most common features seen in the failure of the autonomic nervous system.

Insulin resistance can be associated with overactive bladder and may play a significant role in its pathogenesis in female patients, "Beyond the Abstract," by Hakkı Uzun, MD

Published on Thursday, 04 April 2013 15:12

BERKELEY, CA (UroToday.com) - In this, our small sample-size clinical study, we found a relationship between overactive bladder (OAB) and increased serum insulin levels and HOMA-IR values in female patients.

Validation study of the Self-Assessment Goal Achievement (SAGA) questionnaire for lower urinary tract symptoms - Abstract

Published on Thursday, 04 April 2013 14:46

Background: Patients' treatment goals for overactive bladder (OAB) and other lower urinary tract symptoms (LUTS) may not be aligned with their healthcare provider's goals.

Results of a randomised phase III trial assessing the tolerability and efficacy of mirabegron for the treatment of OAB, "Beyond the Abstract," by Vik Khullar BSc, MD, FRCOG, AKC and Rhiannon Bray, MD

Published on Wednesday, 03 April 2013 12:21

BERKELEY, CA (UroToday.com) - Oral pharmacological treatment options for overactive bladder (OAB) include antimuscarinics as first-line therapy.^[1,2]

A Population-based survey of lower urinary tract symptoms (LUTS) and symptom-specific bother: Results from the Brazilian LUTS epidemiology study (BLUES) - Abstract

Published on Wednesday, 03 April 2013 09:31

PURPOSE: To examine the prevalence of lower urinary tract symptoms (LUTS) and the bother they impose in a population-based sample of adults in Brazil.

A pelvic floor fitness program for older women with urinary symptoms: A feasibility study - Abstract

Published on Tuesday, 02 April 2013 07:16

OBJECTIVE: To determine the feasibility of an adapted pelvic fitness and educational program to control urinary incontinence (UI) and overactive bladder (OAB) symptoms in women over 65 years of age.

Increasing patient preparedness for sacral neuromodulation improves patient-reported outcomes despite leaving objective measures of success unchanged - Abstract

Published on Monday, 01 April 2013 09:23

INTRODUCTION: We assessed how a GSA influenced patient preparedness for, as well as both subjective and objective outcomes of SNS for refractory overactive bladder and/or urge urinary incontinence.

Page 4 of 54